T61477 |
DCeMM2
|
296771-07-8
|
98%
|
|
dCeMM2 is a glue degrader. dCeMM2 prompts an interaction of CDK12-cyclin K with a CRL4B ligase complex, leading to the ubiquitination and degradation of cyclin K...
|
T67778 |
DCeMM1
|
118719-16-7
|
98%
|
|
dCeMM1 is a RBM39 glue degrader. dCeMM1 can re-direct the activity of the CRL4DCAF15 ligase. dCeMM1 can decrease the expression levels of RBM39 in WT KBM7 cells....
|
T1642 |
Lenalidomide
|
191732-72-6
|
98%
|
|
Lenalidomide is a potent inhibitor of TNF-α that, at 10 μM, alters gene expression and cell viability in a range of cancer cell lines.
|
T10765 |
Eragidomide
|
1860875-51-9
|
98%
|
|
Cereblon modulator 1 is a cereblon (CRBN) E3 ligase modulator. It specifically binds to CRBN, thereby affecting the activity of the ubiquitin E3 ligase complex.
|
T2384 |
Pomalidomide
|
19171-19-8
|
98%
|
|
Pomalidomide inhibits TNF-α release in LPS stimulated human PBMCs (IC50: 13 nM). It is an anti-angiogenic agent and an immunomodulator.
|
T10703 |
Mezigdomide
|
2259648-80-9
|
98%
|
|
|
T22922 |
Lenalidomide hemihydrate
|
847871-99-2
|
98%
|
|
Lenalidomide hemihydrate is a TNF-α secretion inhibitor (IC50 = 13 nM). Lenalidomide hemihydrate could bound endogenous CRBN and recombinant CRBN-DNA damage bind...
|
T9849 |
HQ461
|
1226443-41-9
|
98%
|
|
HQ461 is a molecular glue that promotes CDK12-DDB1 interaction to trigger cyclin K degradation, resulting in decreased CDK12 substrate phosphorylation, downregul...
|
T0213 |
Thalidomide
|
50-35-1
|
98%
|
|
Thalidomide is a synthetic derivative of glutamic acid (alpha-phthalimido-glutarimide) with teratogenic, immunomodulatory, anti-inflammatory and anti-angiogenic ...
|